The Neuropathology and Genetics (NPG) Core will perform laboratory analyses on biological fluids collected from living subjects and brain tissue collected at autopsy of participants in the Mayo Alzheimer Disease Research Center (ADRC). The data will be communicated to the Clinical Core using standardized protocols and procedures. The NPG Core will also provide neuropathologic diagnoses and support to research projects related to Alzheimer's disease at the Mayo Clinic.
The specific aims are: 1.) Perform brain autopsies on participants of the ADRC. 2.) Provide neuropathologic evaluations and collect neuropathologic data using standardized neuropathologic methods for gross dissections and neurohistology. 3.) Photograph, map and measure vascular lesions and reach consensus about the clinical significance of vascular lesion to cognitive impairment with regular videoconferences and quarterly clinicopathological conferences in Rochester. 4.) Perform immunostaining with antibodies to alpha-synuclein on all cases with either neuronal loss in the substantia nigra or Lewy bodies. 5.) Characterize non- Alzheimer dementia cases with immunocytochemistry and electron microscopy and provide DNA and tissue samples on these cases to Dr. Mike Hutton who is studying biochemistry and genetics of non-Alzheimer dementias. 6.) Provide fixed and frozen brain samples to Project 1 (PI: Dr. S.-H. Yen). 7.) Quantify postmortem white matter pathology with image analysis for correlative studies in Project 3 (PI: Dr. C.R. Jack). 8.) Perform ELISA assays for A-beta of postmortem brain tissue to estimate amyloid burden for correlative studies. 9.) Provide clinically and pathologically well-characterized tissue samples for research on other projects of Mayo investigators. 10.) Bank blood and CSF and perform apolipoprotein-E genotyping on all subjects in the ADRC. Provide plasma samples to Dr. S.G.Younkin for A-beta assays that are integral to his other research projects.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG016574-01S4
Application #
6396651
Study Section
Project Start
1999-09-30
Project End
2000-04-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Kidana, Kiwami; Tatebe, Takuya; Ito, Kaori et al. (2018) Loss of kallikrein-related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice. EMBO Mol Med 10:
Townley, Ryan A; Botha, Hugo; Graff-Radford, Jonathan et al. (2018) 18F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus. Neuroimage Clin 18:897-902
Arnold Fiebelkorn, Catherine; Vemuri, Prashanthi; Rabinstein, Alejandro A et al. (2018) Frequency of Acute and Subacute Infarcts in a Population-Based Study. Mayo Clin Proc 93:300-306
Li, Zeran; Del-Aguila, Jorge L; Dube, Umber et al. (2018) Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure. Genome Med 10:43
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Baker, Darren J; Petersen, Ronald C (2018) Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives. J Clin Invest 128:1208-1216
Ramanan, Vijay K; Przybelski, Scott A; Graff-Radford, Jonathan et al. (2018) Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults. J Alzheimers Dis 65:1345-1352
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Knopman, David S; Lundt, Emily S; Therneau, Terry M et al. (2018) Joint associations of ?-amyloidosis and cortical thickness with cognition. Neurobiol Aging 65:121-131

Showing the most recent 10 out of 1014 publications